Aspire BioPharma, Inc. • ASBP

Capital at risk.

About Aspire BioPharma, Inc.
Ticker
info
ASBP
Trading on
info
NASDAQ
ISIN
info
-
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Kraig T. Higginson
Headquarters
info
194 Candelero Drive, Humacao, PR, United States, 00791
Employees
info
0
Website
info
https://aspirebiolabs.com
Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company provides Sublingual Aspirin Product, which addresses cardiology emergencies and pain management. It develops formulation for a sublingually administered melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide, as well as formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and several other classes of drugs. The company was founded in 2021 and is based in Humacao, Puerto Rico.
Metrics
BasicAdvanced
Market cap
info
-
P/E ratio
info
-
EPS
info
$0.00
Dividend Yield
info
0.00%
Beta
info
-
Forward P/E ratio
info
0
EBIDTA
info
-
Ex dividend date
info
-
Price & volume
Market cap
info
-
Average daily volume
info
1.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
0
Earnings
EPS
info
$0.00
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
-
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-
52-week High
info
$15.80
52-week Low
info
$0.52
50-day moving average
info
$0.00
200-day moving average
info
$0.00
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
0.00%
ROA (TTM)
info
0.00%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
0M
Float
info
0M
Insiders %
info
-
Institutions %
info
-
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.00
-
-
Q2 • 22Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-0.1M
∞%
Q2 • 24
$0M
$-0.2M
∞%
Q3 • 24
NaN%
151.36%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$5.1M
$4.6M
91.26%
Q2 • 24
$0.2M
$1M
535.55%
Q3 • 24
96.36%
78.65%
486.83%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
-
-
-
-
Q2 • 24
$-0.5M
$0M
$0.5M
$-0.5M
Q3 • 24
-
-
NaN%
NaN%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Aspire BioPharma, Inc. share?
Collapse

Aspire BioPharma, Inc. shares are currently traded for undefined per share.

How many shares does Aspire BioPharma, Inc. have?
Collapse

Aspire BioPharma, Inc. currently has 0M shares.

Does Aspire BioPharma, Inc. pay dividends?
Collapse

No, Aspire BioPharma, Inc. doesn't pay dividends.

What is Aspire BioPharma, Inc. 52 week high?
Collapse

Aspire BioPharma, Inc. 52 week high is $15.80.

What is Aspire BioPharma, Inc. 52 week low?
Collapse

Aspire BioPharma, Inc. 52 week low is $0.52.

What is the 200-day moving average of Aspire BioPharma, Inc.?
Collapse

Aspire BioPharma, Inc. 200-day moving average is $0.00.

Who is Aspire BioPharma, Inc. CEO?
Collapse

The CEO of Aspire BioPharma, Inc. is Kraig T. Higginson.

How many employees Aspire BioPharma, Inc. has?
Collapse

Aspire BioPharma, Inc. has 0 employees.

What is the market cap of Aspire BioPharma, Inc.?
Collapse

The market cap of Aspire BioPharma, Inc. is null.

What is the P/E of Aspire BioPharma, Inc.?
Collapse

The current P/E of Aspire BioPharma, Inc. is null.

What is the EPS of Aspire BioPharma, Inc.?
Collapse

The EPS of Aspire BioPharma, Inc. is $0.00.

What is the PEG Ratio of Aspire BioPharma, Inc.?
Collapse

The PEG Ratio of Aspire BioPharma, Inc. is null.